Massachusetts cannabis DEA registration

Where things stand for an MTC

• If you filed a complete application and fee between April 28 and June 26, 2026: you are a Timely Applicant with conditional operating authority under § 1301.13(k)(7) while the application is pending. Under the October 30 federal guidance you may do business only with other Timely Applicants and DEA registrants, you are expected to verify each one and keep the record, and compliant supply chains are expected by November 29, 2026. What the guidance means and how to check a partner’s status.
• If you filed after June 26: you are in the standard queue with no conditional operating authority, and until the registration issues, Timely Applicants and registrants may not do business with you.
• If you did not file: the standard queue remains open. Your medical channel is a Schedule III substance federally whether or not you registered, and your posture as an unregistered operator is a decision to make, not a default to drift into. The unregistered operator’s exposure.
• Either way, the DEA has started saying no. Orders to show cause against a Minnesota dispensary and a D.C. dispensary, and a denial of MedPharm’s bulk-manufacturer application, show the agency reading state licensing frameworks, patient-certification rules, and affiliated-entity control closely. Each has a Massachusetts analogue, covered below.

To find out where you stand: call or text (916) 572-6445, email Ryan@Kocotlaw.com, or book a consultation.

How § 1301.13(k) reads a CCC license

The April 2026 order rescheduled marijuana to Schedule III only when it is in an FDA-approved drug product or subject to a state medical marijuana license. In Massachusetts that means the Medical Marijuana Treatment Center program under M.G.L. ch. 94I and 935 CMR 501. Every Marijuana Establishment license under M.G.L. ch. 94G and 935 CMR 500, from cultivators and product manufacturers to retailers, microbusinesses, cooperatives, transporters, delivery licensees, and social consumption establishments, sits outside Schedule III. One regulator administers both programs, which is efficient for licensees and changes nothing federally. Under § 1301.13(k)(2), a current CCC MTC license is conclusive evidence that the MTC is authorized under state law for the licensed activity. Under § 1301.13(k)(3), each DEA registration suspends automatically if the MTC license is suspended, revoked, or expires, and federal scope can never exceed state scope.

Co-located MTC and ME operations, after Minnesota

Most MTCs operate medical and adult-use from the same premises under separate but parallel CCC licenses, with shared inventory rooms, shared staff, and shared or adjacent retail floors, a pattern the CCC formalized at 935 CMR 500.140 and 501.140. The DEA’s Minnesota order to show cause objects to a state license that itself authorizes both medical and recreational dispensing, calling it outside the federal definition of a state medical marijuana license and short on protection against diversion. The Minnesota order and what it means.

Massachusetts differs on the formal point. The MTC license and the ME license are separate instruments, so the medical license is not the one authorizing adult-use sales. That is a better position than Minnesota’s. It does not resolve the DEA’s broader concern. Medical and adult-use product sold from the same floor, by the same staff, under the same ownership, is exactly the fact pattern the agency’s reasoning reaches, and in denying MedPharm the DEA looked past the applicant to affiliates under common management and treated their recreational production as diversion. Structure, affiliates, and optionality.

MTC vertical integration and the multi-registration footprint

Under 935 CMR 501.050 an MTC cultivates, processes, and dispenses as a single licensed entity through up to three medical dispensary locations. The federal pathway recognizes three categories, manufacturer, distributor, and dispenser, and under § 1301.13(k)(1)(v) one entity may hold all of them. An MTC covering its full medical operation typically holds one manufacturer registration, one distributor registration, and one dispenser registration per medical dispensary, five in many cases. Each is applied for, renewed, inspected, and suspended separately, and each has its own fee; confirm current fees at filing. The intake question is which registrations the actual scope of medical activity requires.

Certification records in Massachusetts

Section 1301.13(k)(5) accepts a certification or other document that state law deems sufficient for medical access in place of a prescription, so long as it is dated and signed the day it is issued, bears the patient’s full name and address, and carries the name, address, and state license number of the practitioner who signed it. The DEA’s order to show cause against a D.C. dispensary objects to that District’s patient self-certification pathway on exactly this ground: no practitioner signature, no practitioner information. The D.C. order.

Massachusetts certifications come from certifying healthcare providers under 935 CMR 501.020, Massachusetts-licensed and, where their license type requires it, DEA-registered, and the CCC’s patient registration system tracks the provider’s credentials. The framework generally captures the federal elements. Records produced under the Department of Public Health framework before 2018 followed different documentation conventions than CCC-era records, so a pre-filing review should confirm that each MTC’s records, especially the older ones, carry all five elements.

Article 23, and the quotas being developed

The MTC’s manufacturer registration carries Article 23 of the Single Convention, implemented at § 1301.13(k)(6). The registration must specify the areas in which cultivation is permitted. The registrant sets a nominal price for its crop, the DEA buys it at that price and sells it back at the same price plus an administrative fee, and harvested crops must be stored where the DEA has access until that paper transaction is complete. CCC premises plans under 935 CMR 501.110 are the starting point for the cultivation-area designation, not the finished product.

Quotas were always part of this framework. The April order directs the DEA to consider treaty requirements, including quota requirements, when it evaluates an application. In a notice scheduled for Federal Register publication on November 10, 2026, the DEA confirmed that it is developing separate production quotas for Schedule III marijuana, marijuana extracts, and naturally derived delta-9-THC, with the amounts to follow in their own notice. A CCC cultivation tier is a canopy authorization. A federal quota is a production quantity tied to estimated legitimate need. The first does not predict the second, and a federal allowance would not let an MTC exceed its state tier. What the quota notice does and does not tell us.

METRC, the DPH-to-CCC transition, and host communities

Under § 1301.13(k)(4), the DEA accepts state-required reports, records, and forms to the maximum extent permissible. METRC inventory and transfer data under 935 CMR 501.105 will likely carry the federal biennial inventory and the transfer records between MTC sites, and the dual MTC and ME account structure is the foundation for medical-versus-adult-use tracking. METRC was not built for Single Convention statistical returns, so a separate federal reporting overlay is likely for the manufacturer registration.

An MTC licensed before 2018 has a history under the Department of Public Health and 105 CMR 725 as well as the CCC and 935 CMR 501. The current CCC license is the federal predicate; DPH-era deficiency findings and corrective actions remain in the recordkeeping inventory and can surface in a public-interest review, so inventory them before filing. Host Community Agreements are not a federal requirement, but a dispute that threatens the CCC license threatens every registration resting on it through § 1301.13(k)(3). Municipal opt-outs under M.G.L. ch. 94G § 3 reach Marijuana Establishments; MTCs operate under separate state authorization but still need local zoning and site approval in good standing.

§ 280E for a Massachusetts MTC

Schedule III placement removes state-medical-licensed activity from the reach of 26 U.S.C. § 280E prospectively. Massachusetts conforms to federal § 280E for corporate excise purposes, so MTCs have carried the disallowance at both levels, and federal relief on the medical channel should flow through to the state as a conformity matter; tax counsel should verify the mechanics. The co-located ME remains subject to § 280E at both levels, so the allocation of cost of goods and operating expense between the two licenses is a tax-accounting matter with a defensible methodology behind it. The AG Order encourages Treasury to consider retrospective relief; none has been issued. Kocot Law coordinates the federal eligibility analysis and refers the tax work to retained tax counsel.

What the order does not do

Frequently asked questions

Massachusetts documents to gather

• Current CCC MTC license and all amendments, and the co-located ME license if any
• License history across the DPH-to-CCC transition
• Premises plans under 935 CMR 501.110 for cultivation, manufacturing, and each medical dispensary, with canopy and processing areas identified
• CCC ownership and financial-interest disclosures, and the same for any affiliated entity on the ME side
• METRC enterprise structure showing the separate MTC and ME accounts
• Patient certification verification procedures, dispensing logs, and certifying provider registration records
• Transport SOPs, manifests, and vehicle inventory for movement between sites
• The separation protocol for the co-located premises: inventory, point-of-sale characterization, staff, storage access
• Host Community Agreements and local approvals for each location
• For Timely Applicants: the partner verification ledger and the DEA list entries relied on
• DPH-era deficiency findings and corrective actions; CCC inspection and enforcement records since 2018
• Any pending CCC amendment, change of control, or change-of-location application
• Insurance certificates required under 935 CMR 501

What Kocot Law handles

Attorney advertising. This page is general information about federal and Massachusetts law as of its last review and is not legal advice. Reading it, calling, or submitting a form does not create an attorney-client relationship; none is formed unless and until Kocot Law completes a conflict check and both parties sign an engagement letter. Federal guidance in this area changes frequently; confirm the current state of the rule before relying on any statement here. The order discussed is AG Order No. 6754-2026, 91 Fed. Reg. 22714 (April 28, 2026). Prior results do not guarantee a similar outcome.